News

JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020

Access the event and schedule of presenting companies at virtualinvestorsummit.com

Live audio webcast presentations and interactive Q&A

Company presentations will be held from 10 AM-12 PM ET and 1 PM-3 PM ET on both days

BOSTON/NEW YORK/New Jersey — April 9, 2020 —JTC Team (“JTC”) and LaVoieHealthScience (“LHS”), today announced their partnership to host the April 2020 Virtual Investor Summit on April 22nd and 23rd from 10:00 AM – 12:00 PM ET and 1:00 PM – 3:00 PM ET on both days. The Virtual Investor Summit will feature public and private companies from multiple industries including life sciences/biotech, infrastructure and transportation. As part of the event, management teams will present a live audio webcast accompanied by a slide presentation and be available to participate in virtual Q&A sessions immediately following their presentation.

Investors, media and interested parties can access the event schedule and individual company webcast details at the event website, virtualinvestorsummit.com.

Public companies to present at the Virtual Investor Summit include:

Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZS), American Resources Corporation (NASDAQ: AREC), Ceapro Inc. (OTCQX: CRPOF; TSX-V: CZO), Cocrystal Pharma Inc. (NASDAQ: COCP), Guardion Health Sciences, Inc. (NASDAQ: GHSI), Matinas BioPharma (NYSE AMER: MTNB), Outlook Therapeutics, Inc. (NASDAQ: OTLK), TFF Pharmaceuticals Inc. (NASDAQ: TFFP), and Xenetic Biosciences Inc. (NASDAQ: XBIO).

Private companies to present include:

Celavie Biosciences & Celavet, Inc., Charge, Inc., DeMelle OncoPharma,  EuMentis Therapeutics, Omega Therapeutics and SIRION Biotech.

For more information about the event, please visit the conference website at virtualinvestorsummit.com or contact info@virtualinvestorsummit.com.

About JTC Team, LLC

JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness and achieve your goals. JTC was founded over 8 years ago and has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company’s client roster over the years has included both public and private companies across the Life Sciences and Technology industries to help them establish and execute their corporate communications, raise awareness and build shareholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, access and marketing. The firm provides public relations, investor relations and strategic consulting to build recognition and increase sales and value for health science innovations. The agency has received over 50 awards in recognition of the work it has done for its health and science industry-leading clients and was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies, as well as ranked on the O’Dwyer’s list of Healthcare Public Relations Firms. In January 2020, LHS and Omnicom Public Relations Group (OPRG), a division of Omnicom Group (NYSE: OMC), formed a strategic alliance to bring global clients a broader set of integrated health- and science-experienced teams.

Contacts:

JTC Team:
Jenene Thomas
T: +1 (833) 475-8247
jtc@jtcir.com

LHS:
Katie Gallagher
Account Director
kgallagher@lavoiehealthscience.com

Featured Event

No Events

Recent News